Navitas Assets (Cicletanine Business) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Navitas Assets (Cicletanine Business) General Information

Description

Developer of hypertension drug. The company develops and produces drug, oral drug agents and treatments for pulmonary arterial hypertension.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Acquirer
Corporate Office
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Navitas Assets (Cicletanine Business) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Navitas Assets (Cicletanine Business)‘s full profile, request access.

Request a free trial

Navitas Assets (Cicletanine Business) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Navitas Assets (Cicletanine Business)‘s full profile, request access.

Request a free trial

Navitas Assets (Cicletanine Business) FAQs

  • Where is Navitas Assets (Cicletanine Business) headquartered?

    Navitas Assets (Cicletanine Business) is headquartered in .

  • What industry is Navitas Assets (Cicletanine Business) in?

    Navitas Assets (Cicletanine Business)’s primary industry is Drug Discovery.

  • Is Navitas Assets (Cicletanine Business) a private or public company?

    Navitas Assets (Cicletanine Business) is a Private company.

  • What is the current valuation of Navitas Assets (Cicletanine Business)?

    The current valuation of Navitas Assets (Cicletanine Business) is 000.00.

  • What is Navitas Assets (Cicletanine Business)’s current revenue?

    The current revenue for Navitas Assets (Cicletanine Business) is 000000.

  • Who are Navitas Assets (Cicletanine Business)’s investors?

    Navitas Assets (Wyoming) has invested in Navitas Assets (Cicletanine Business).

  • When was Navitas Assets (Cicletanine Business) acquired?

    Navitas Assets (Cicletanine Business) was acquired on 29-May-2008.

  • Who acquired Navitas Assets (Cicletanine Business)?

    Navitas Assets (Cicletanine Business) was acquired by Gilead Sciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »